Tanke Biosciences Earnings Estimate

Tanke Biosciences Earnings per Share Projection vs Actual

About Tanke Biosciences Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Tanke Biosciences earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Tanke Biosciences estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Tanke Biosciences fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Tanke Biosciences Corporation, through its subsidiaries, develops, produces, markets, and sells animal nutrition and feed additive products. Tanke Biosciences Corporation was founded in 1989 and is headquartered in Guangzhou, the Peoples Republic of China. TANKE BIOSCIENCES operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 130 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Tanke Pink Sheet

Tanke Biosciences financial ratios help investors to determine whether Tanke Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tanke with respect to the benefits of owning Tanke Biosciences security.